Pharmaceutical combination composition comprising at least one PKC inhibitor and at least one JAK3 kinase inhibitor for treating autoimmune disorders

Details for Australian Patent Application No. 2007228997 (hide)

Owner Novartis AG

Inventors Maibucher, Axel

Agent Davies Collison Cave

Pub. Number AU-A-2007228997

PCT Pub. Number WO2007/107318

Priority 0605691.5 21.03.06 GB

Filing date 19 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 31/404 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

11 September 2008 PCT application entered the National Phase

  PCT publication WO2007/107318 Priority application(s): WO2007/107318

16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229002-Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy

2007228996-Salt of aliskiren with sulfuric acid